Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Fourteen investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $24.00.
Several equities research analysts recently commented on the stock. Robert W. Baird set a $20.00 target price on shares of Bath & Body Works in a research report on Wednesday, December 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Tuesday, March 3rd. JPMorgan Chase & Co. dropped their price target on shares of Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a research note on Thursday, November 20th. Zacks Research upgraded shares of Bath & Body Works from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 20th. Finally, Telsey Advisory Group boosted their price objective on shares of Bath & Body Works from $23.00 to $25.00 and gave the stock a “market perform” rating in a research note on Thursday, March 5th.
Get Our Latest Analysis on Bath & Body Works
Institutional Investors Weigh In On Bath & Body Works
Bath & Body Works Stock Down 1.3%
Shares of BBWI opened at $20.02 on Friday. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $34.66. The business has a 50-day simple moving average of $22.30 and a two-hundred day simple moving average of $22.90. The stock has a market cap of $4.03 billion, a PE ratio of 6.35, a PEG ratio of 2.03 and a beta of 1.48.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. During the same period last year, the firm posted $2.09 earnings per share. The business’s revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts expect that Bath & Body Works will post 3.3 EPS for the current year.
Bath & Body Works Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 annualized dividend and a yield of 4.0%. Bath & Body Works’s payout ratio is presently 25.40%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Stories
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
